15 percent increase in trial diversity through 2026 digital enrollment
By the second half of 2026, the pharmaceutical industry has finally begun to bridge the "diversity gap" that has plagued clinical research for decades. Digital enrollment platforms, available in over 50 local dialects, are now the standard for major Phase II and III programs. This shift is particularly evident in the African and Southeast Asian regions, where mobile-first recruitment strategies...
0 Commentarios 0 Acciones 241 Views 0 Vista previa